Celltrion's Anticancer Biosimilar Debuts In Japan - Life Sciences, Biotechnology & Nanotechnology

According to news reports, Celltrion recently launched VEGZELMA (bevacizumab) in Japan. In September 2022, the drug received sales approval from the Japanese Ministry of Health, Labor and Welfare...

Related Keywords

New York ,United States ,Frankfurt ,Brandenburg ,Germany ,Kurnit Klein Selz ,Lorna Doone ,Foley Lardner ,Sheppard Mullin Richter Hampton ,Foley Hoag ,Life Sciences ,Drug Administration ,Health Products Compliance Guidance On ,Federal Trade Commission ,Health Products Compliance Guidance ,Western District ,Mondelez Global ,False Claims Act ,Drug Omnibus Reform Act ,Mondaq ,Bevacizumab ,Biosimilars News ,Celltrion ,Vegzelma ,Food ,Drugs ,Healthcare ,Iotechnology Amp Nanotechnology , ,